Exscientia downgraded to Equal Weight from Overweight at Barclays

Barclays analyst Peter Lawson downgraded Exscientia to Equal Weight from Overweight with a $5 price target after the company entered into a definitive agreement with Recursion. Under the terms of the transaction agreement, Exscientia shareholders will receive 0.7729 shares of Recursion Class A common stock for each Exscientia ordinary share they own, with fractional shares paid in cash.